Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine

American Journal of Gastroenterology

Volumn 94, Issue 11, 1999, Pages 3248-3253

  Korelitz, Burton I ^a   Mirsky, Felice J ^a   Fleisher, Mark R ^a   Warman, Jonathan I ^a   Wisch, Nathaniel ^a   Gleim, Gilbert W ^a  

^a LENOX HILL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTOPURINE;

ADULT; AGED; ARTICLE; BLOOD DYSCRASIA; BRAIN LYMPHOMA; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COLORECTAL CANCER; CROHN DISEASE; ENTERITIS; FOLLOW UP; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; QUALITY OF LIFE; ULCERATIVE COLITIS;

6-MERCAPTOPURINE; ABDOMINAL NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; BREAST NEOPLASMS; COLITIS, ULCERATIVE; CROHN DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; INTESTINAL NEOPLASMS; LEUKEMIA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS; TIME FACTORS;

EID: 0032754121     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00589-4     Document Type: Article

References (36)

1. Present D.H., Meltzer S.J., Krumholz M.P., et al. 6-Mercaptopurine in the management of inflammatory bowel disease Short- and long-term toxicity . Ann Intern Med. 111:1989;641-649.
2. Korelitz B.I., Fleisher M.R., Sacknoff A.L. Should toxicity to 6-mercaptopurine serve to discourage long term maintenance therapy of inflammatory bowel disease? Experience of the past quarter century. Am J Gastroenterol. 91:1996;A665.
3. Haber C.J., Meltzer S.J., Present D.H., et al. Natural course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease. Gastroenterology. 91:1996;982-986.
4. Korelitz B.I., Glass J.L., Wisch N. Long-term immunosuppressive therapy of ulcerative colitis. Am J Dig Dis. 18:1973;317-322.
5. Penn I. Chemical immunosuppression and human cancer. Cancer. 34:1974;1474-1490.
6. Present D.H., Korelitz B.I., Wisch N., et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med. 302:1980;981-987.
7. Korelitz B.I., Adler D.J., Mendelsohn R.A., et al. Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease. Am J Gastroenterol. 88:1993;1198-1205.
8. Pearson D.C., May G.R., Fick G.H., et al. Azathioprine and 6-Mercaptopurine in Crohn's Disease. A Meta-Analysis. Ann Intern Med. 122:1995;132-142.
9. Kirk A.P., Lennard-Jones J.E. Controlled trial of azathioprine in chronic ulcerative colitis. Br Med J. 284:1962;1291-1292.
10. Adler D.J., Korelitz B.I. The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. Am J Gastroenterol. 85:1990;217-222.
11. George J., Present D.H., Pou R., et al. The Long-term outcome of ulcerative colitis treated with 6-mercaptopurine. Am J Gastroenterol. 91:1996;1711-1714.
12. Bouhnik Y., Lemann M., Mary J.-Y., et al. Long-term Follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet. 347:1996;215-219.
13. Kirshner B.S. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology. 115:1998;813-821.
14. Woolrich A.J., DaSilva M.D., Korelitz B.I. Surveillance in the routine management of ulcerative colitis Productive value of low grade dysplasia . Gastroenterology. 103:1992;431-438.
15. Choi P.M., Zeilg M.P. Similarity of Colorectal Cancer in Crohn's disease and ulcerative colitis - Implications for carcinogenesis and prevention. Gut. 35:1994;950-954.
16. Connell W.R., Kamm M.A., Dickson M., et al. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet. 343:1994;1249-1252.
17. Jelliger K., Kothbauer P., Weiss R., et al. Primary malignant lymphoma of the CNS and polyneuropathy in a patient with necrotizing vasculitis treated with immunosuppression. J Neurol. 220:1979;259-268.
18. Glick S.N., Teplick S.K., Goodman L.R., et al. The development of lymphoma in patients with Crohn's disease. Radiology. 153:1984;337-339.
19. Greenstein A.J., Mullin G.E., Strauchen J.A., et al. Lymphoma in inflammatory bowel disease. Cancer. 69:1992;1119-1123.
20. Yau Y.-H., O'Sullivan M.G., Signorini D., et al. Primary lymphoma of central nervous system in immunocompetent patients in south-east Scotland. Lancet. 348:1996;890.
21. Kinlen L.J. Immunosuppressive therapy and acquired immunological disorders. Cancer Res. 52:(suppl):1992;5474-5476.
22. Kinlen L.J. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppression treatment. Am J Med. 78:(suppl 1A):1985;44-49.
23. Greenstein A.J., Sachar D.B., Shafir M., et al. Malignant melanoma in inflammatory bowel disease. Am J Gastroenterol. 89:1992;317-320.
24. Eng C., Farraye F.A., Shulman L.N., et al. The Association between the myelodysplastic syndromes and Crohn's disease. Ann Intern Med. 117:1992;661-662.
25. Mir Madjlessi S.H., Farmer R.G., Werck C.K. Inflammatory bowel disease and leukemia. Dig Dis Sci. 31:1986;1025-1031.
26. Giron J.A., Yepra M., Solovera J.J., et al. Crohn's Disease and leukemia. Dig Dis Sci. 30:1985;410-411.
27. Colm E.M., Pearlstine B. Inflammatory bowel disease and leukemia. J Clin Gastroenterol. 6:1984;33-35.
28. Halmes L., Knorring S., Elonen E. Development of acute myelocytic leukemia in patients with Crohn's disease. Dig Dis Sci. 35:1990;1553-1556.
29. Ori S., Sugai T., Nakano O., et al. Acute promyelocytic leukemia in Crohn's disease. Case report and review of the literature. J Clin Gastroenterol. 13:1991;325-327.
30. Hatakr K., Tanaka M., Muroi K. Leukemia risk in Crohn's disease. Lancet. 347:1996;1049-1050.
31. Ekbom A., Helmick C., Zack M., et al. Extracolonic malignancies in inflammatory bowel disease. Cancer. 67:1991;2015-2019.
32. Persson P.-G., Karlen P., Bernell O., et al. Crohn's disease and cancer A population based cohort study . Gastroenterology. 107:1994;1675-1679.
33. Greenstein A.J., Gennuso R., Sachar D.B., et al. Extra-intestinal cancers in inflammatory bowel disease. Cancer. 56:1985;2914-2921.
34. Kim P.S., Zlatanic J., Korelitz B.I., et al. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease. Am J Gastroenterol. 94:1999;3254-3257.
35. Mendelsohn R.A., Korelitz B.I., Gleim G.W. Death from Crohn's disease Lessons from a personal experience . J Clin Gastroenterol. 20:1995;22-26.
36. Present DH. Selected summaries - Inflammatory bowel diseases. 1995;1:166-7 (comment).